RT @Aiims1742: Ph1b of a chemokine (C-C motif) receptor 2 (CCR2) antagonist (PF-04136309) in combination with nab-paclitaxel/Gemcitabine i…
RT @Aiims1742: Ph1b of a chemokine (C-C motif) receptor 2 (CCR2) antagonist (PF-04136309) in combination with nab-paclitaxel/Gemcitabine i…
RT @Aiims1742: Ph1b of a chemokine (C-C motif) receptor 2 (CCR2) antagonist (PF-04136309) in combination with nab-paclitaxel/Gemcitabine i…
RT @Aiims1742: Ph1b of a chemokine (C-C motif) receptor 2 (CCR2) antagonist (PF-04136309) in combination with nab-paclitaxel/Gemcitabine i…
RT @Aiims1742: Ph1b of a chemokine (C-C motif) receptor 2 (CCR2) antagonist (PF-04136309) in combination with nab-paclitaxel/Gemcitabine i…
I think one was in early disease and the other on stage 4.
RT @Aiims1742: Ph1b of a chemokine (C-C motif) receptor 2 (CCR2) antagonist (PF-04136309) in combination with nab-paclitaxel/Gemcitabine i…
RT @Aiims1742: Ph1b of a chemokine (C-C motif) receptor 2 (CCR2) antagonist (PF-04136309) in combination with nab-paclitaxel/Gemcitabine i…
RT @Aiims1742: Ph1b of a chemokine (C-C motif) receptor 2 (CCR2) antagonist (PF-04136309) in combination with nab-paclitaxel/Gemcitabine i…
RT @Aiims1742: Ph1b of a chemokine (C-C motif) receptor 2 (CCR2) antagonist (PF-04136309) in combination with nab-paclitaxel/Gemcitabine i…
Ph1b of a chemokine (C-C motif) receptor 2 (CCR2) antagonist (PF-04136309) in combination with nab-paclitaxel/Gemcitabine in metastatic #PancreaticCancer High incidence of pulmonary toxicity with this combo No significant improvement in RR https://t.co/D8